M&A Deal Summary

Generate Life Sciences Acquires Cell Care

On June 2, 2021, Generate Life Sciences acquired life science company Cell Care from CPE Capital

Acquisition Highlights
  • This is Generate Life Sciences’ 1st transaction in the Life Science sector.
  • This is Generate Life Sciences’ 1st transaction in Australia.

M&A Deal Summary
Date 2021-06-02
Target Cell Care
Sector Life Science
Buyer(s) Generate Life Sciences
Sellers(s) CPE Capital
Deal Type Add-on Acquisition

Target

Cell Care

Moorabbin, Australia
Cell Care operates a purpose-built, state-of-the-art stem cell laboratory and storage facility. Cell Care is a family cord blood and tissue bank that has been collecting, processing, and storing cord stem cells for over ten years. Cell Care was founded in 2009 and is based in Moorabbin, Australia.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Generate Life Sciences

Los Angeles, California, United States
Category Company
Sector Life Science
Revenue 250M USD (2021)
DESCRIPTION

Generate Life Sciences is a life sciences company helping to grow and protect families through reproductive, newborn stem cell, genetic screening, medical device, and healthcare technology services. The company serves families from preconception to post-birth. Its brands CBR (Cord Blood Registry), California Cryobank, Donor Egg Bank USA, NW Cryobank, ReadyGen, Kitazato USA, and Donor Application are pioneering leaders that have helped nearly one million families. Headquartered in Los Angeles, Generate operates facilities in Tucson, New York, Boston, Palo Alto, and Rockville, MD.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 2 of 2
Country (Australia) 1 of 1
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-15 Cord Blood America

Las Vegas, Nevada, United States

Cord Blood America, Inc. is a provider of cord blood and cord tissue stem cell services. Cord Blood America is based in Las Vegas, Nevada.

Buy -

Seller(S) 1

SELLER

CPE Capital

Sydney, Australia

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1987
PE ASSETS 3.8B USD
Size Large
Type Sector Agnostic
DESCRIPTION

CHAMP Private Equity is an Australian private equity firm focused on seed, expansion stage, and buyout investments across a range of industry sectors. CHAMP's buyout practice looks for businesses valued A$100 million and A$750 million, requiring at least A$30 million in equity capital. The Firm primarily looks for businesses operating in Australia and New Zealand. CHAMP is affiliated with New York based private equity firm Castle Harlan. CHAMP Private Equity was formed in 2000 and is based in Sydney.

DEAL STATS #
Overall 24 of 27
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 10 of 11
Country (Australia) 22 of 24
Year (2021) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-05-31 Gourmet Food

Dandenong South, Australia

Gourmet Food manufactures, imports, and distributes premium crackers, sugar-free biscuits, and chilled and packaged seafood in Australia, New Zealand and other overseas markets. Gourmet Food is based in Dandenong South, Australia.

Sell AU$454M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-26 Jaybro Group

Arndell Park, Australia

Jaybro Group is a distributor of consumables to civil infrastructure and construction contractors. Jaybro's in-house graphic design team and production facilities also enable customized signs to be delivered to construction sites within 24 hours. Jaybro Group was founded in 1996 and is based in Arndell Park, Australia.

Sell -
Mergr

Product

Company

Legal